PRECIGEN CCO sells shares to cover RSU taxes

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Commercial Officer Phil Tennant reported a tax-related share sale. On May 28, 2026, he sold 30,272 shares of common stock at $4.36 per share in a sell-to-cover transaction tied to tax withholding on restricted stock units that vested on May 23, 2026. Following this transaction, he directly holds 139,369 common shares, and the filing shows no remaining derivative positions.

Insider Trade Summary

Net Seller: 30,272 shares

Net Sell 1 txn

Insider Tennant Phil

Role Chief Commercial Officer

Sold 30,272 shs ($132K)

Type	Security	Shares	Price	Value
Sale	Common Stock	30,272	$4.36	$132K

Holdings After Transaction: Common Stock — 139,369 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.

Key Figures

Shares sold: 30,272 shares Sale price: $4.36 per share Shares held after: 139,369 shares +1 more

4 metrics

Shares sold 30,272 shares Common stock sold on May 28, 2026

Sale price $4.36 per share Price for the 30,272 shares sold

Shares held after 139,369 shares Direct holdings after transaction

Net share direction -30,272 shares Net buy/sell shares from transactionSummary

Key Terms

sell-to-cover transaction, restricted stock units, tax withholding obligations, open-market sale

4 terms

sell-to-cover transaction financial

"Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction"

A sell-to-cover transaction is when a person granted company stock (for example as part of compensation or option exercise) immediately sells enough of those shares to pay required taxes or exercise costs and keeps the rest. Think of it like cashing part of a bonus to cover the tax bill; it provides necessary cash without the holder needing outside funds. Investors watch these sales because they increase trading volume and slightly reduce insider holdings, but they often reflect routine tax or cost management rather than a judgment on the company’s prospects.

restricted stock units financial

"to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting"

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PRECIGEN (PGEN) report for Phil Tennant?

PRECIGEN reported that Chief Commercial Officer Phil Tennant sold 30,272 common shares on May 28, 2026 at $4.36 per share. The transaction was a sell-to-cover sale related to tax withholding on recently vested restricted stock units.

Was the PGEN insider sale by Phil Tennant an open-market sale?

The filing classifies the transaction as an open-market sale, but the footnote explains it was a sell-to-cover transaction. Shares were sold specifically to satisfy tax withholding obligations from restricted stock units vesting on May 23, 2026.

How many PRECIGEN (PGEN) shares does Phil Tennant hold after this transaction?

After the tax-related sale, Phil Tennant directly holds 139,369 shares of PRECIGEN common stock. This post-transaction holding figure comes directly from the Form 4 and reflects his remaining ownership following the 30,272-share sell-to-cover transaction.

What price was received in Phil Tennant’s PGEN share sale?

The reported sale price for Phil Tennant’s transaction was $4.36 per share of PRECIGEN common stock. This price applies to the 30,272 shares sold in the sell-to-cover transaction to meet tax withholding obligations on vested restricted stock units.

Why did Phil Tennant sell PRECIGEN (PGEN) shares according to the Form 4?

The Form 4 footnote states the 30,272 shares were sold in a sell-to-cover transaction to satisfy tax withholding obligations. These obligations arose when his restricted stock units vested on May 23, 2026, making the sale compensation- and tax-driven.

Does the Tennant Form 4 for PRECIGEN (PGEN) show option exercises or derivatives?

The Form 4 indicates no derivative transactions or remaining derivative positions for Phil Tennant. The filing shows only a single non-derivative transaction: the 30,272-share sell-to-cover sale of PRECIGEN common stock to cover tax withholding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:28 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tennant Phil

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MARYLAND 20876

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		S		30,272(1)	D	$4.36	139,369	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.

	/s/ Phil Tennant, by Donald P. Lehr, as attorney-in-fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)